SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Dr. Andrés Rodríguez - 17 July, 2026 0

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

Dr. Andrés Rodríguez - 16 July, 2026 0

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

Dr. Andrés Rodríguez - 15 July, 2026 0

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso - Políticas de privacidad.

Tag: SAFE-PROTECT

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage...

Últimas Noticias

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

Noticias Institucionales

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

Institutional Statement: SOLACI Expresses Its Solidarity with the People of Venezuela

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

Accesos